#Antimicrobial Resistance
2 articles with this tag
Funding Round
SNIPR Biome Secures €35M Series B for CRISPR Therapies
SNIPR Biome, a Danish biotech, secured €35 million in Series B funding. New investors Cystic Fibrosis Foundation and SPRIN-D joined the round, alongside existing backers. This capital will advance its microbial CRISPR-medicine development, including therapies for cystic fibrosis and antimicrobial resistance.
6 months ago
Funding Round
SNIPR Biome Secures €35M Series B for CRISPR Therapies
Copenhagen-based SNIPR Biome , a Danish biotech scale-up, secured €35 million in Series B funding.
6 months ago